We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

2 hedge funds and large institutions have $20.7K invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 228 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

99% less funds holding

Funds holding: 231 → 2 (-229)

100% less funds holding in top 10

Funds holding in top 10: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $6.42B → $20.7K (-$6.42B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 228

Holders
2
Holders Change
-229
Holders Change %
-99.13%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
228
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$297

Top Sellers

Rank Fund Capital Flow
1
BCI
Bain Capital Investors
Massachusetts
-$2.69B
2
PA
Perceptive Advisors
New York
-$441M
3
ACA
Avoro Capital Advisors
New York
-$308M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$293M
5
BlackRock
BlackRock
New York
-$146M
Name Holding Trade Value Shares
Change 		Change in
Stake
NYLIM
76
New York Life Investment Management
New York
– -$7.31M -178,765 Closed
GLA
77
Great Lakes Advisors
Illinois
– -$7.05M -172,337 Closed
GCIA
78
Gabelli & Co Investment Advisers
New York
– -$6.72M -164,345 Closed
CT
79
ClearAlpha Technologies
Connecticut
– -$6.11M -149,438 Closed
Swiss National Bank
80
Swiss National Bank
Switzerland
– -$5.86M -143,200 Closed
CG
81
Carmignac Gestion
France
– -$5.81M -142,015 Closed
N
82
Nuveen
North Carolina
– -$5.66M -138,380 Closed
Tudor Investment Corp
83
Tudor Investment Corp
Connecticut
– -$5.17M -126,538 Closed
SAM
84
Silphium Asset Management
United Kingdom
– -$5.04M -123,314 Closed
California State Teachers Retirement System (CalSTRS)
85
California State Teachers Retirement System (CalSTRS)
California
– -$4.94M -120,723 Closed
Canada Pension Plan Investment Board
86
Canada Pension Plan Investment Board
Ontario, Canada
– -$4.64M -113,500 Closed
EP
87
Eversept Partners
New York
– -$4.5M -110,010 Closed
Susquehanna International Group
88
Susquehanna International Group
Pennsylvania
– -$4.45M -108,832 Closed
Two Sigma Advisers
89
Two Sigma Advisers
New York
– -$4.16M -101,700 Closed
M
90
Murchinson
Ontario, Canada
– -$4.09M -100,000 Closed
HS
91
HighVista Strategies
Massachusetts
– -$3.97M -97,200 Closed
ACM
92
ADAR1 Capital Management
Texas
– -$3.82M -93,350 Closed
UBS AM
93
UBS AM
Illinois
– -$3.72M -90,932 Closed
CC
94
Centiva Capital
New York
– -$3.68M -90,000 Closed
RhumbLine Advisers
95
RhumbLine Advisers
Massachusetts
– -$3.59M -87,810 Closed
LSAG
96
Lake Street Advisors Group
New Hampshire
– -$3.43M -83,857 Closed
YIH
97
Y-Intercept (HK)
Hong Kong
– -$3.21M -78,576 Closed
YCM
98
Yakira Capital Management
Connecticut
– -$3.02M -73,829 Closed
Legal & General Group
99
Legal & General Group
United Kingdom
– -$3.02M -73,771 Closed
BFM
100
Boothbay Fund Management
New York
– -$3M -73,395 Closed
2 3
4
5 6

CERE Hedge Fund Activity: Q3 2024 in Review

2 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q3 2024, worth a combined $20.7K — down 100% from $6.42B a quarter earlier.

Sellers outnumbered buyers: 228 funds closed out of CERE and 0 opened new positions — a net loss of 228 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $297. The largest seller was Bain Capital Investors, exiting entirely with an estimated $2.69B sold.

  • 2 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q3 2024, down from 231 in Q2 2024.
  • Funds reported $20.7K of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q3 2024 and 228 closed out, a net change of -228 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q3 2024 was Blue Trust Inc, an estimated $297 added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q3 2024 was Bain Capital Investors, an estimated $2.69B sold.

Based on aggregated 13F filings for Q3 2024.